Gilead Sciences appoints new head of legal
Biopharmaceutical company Gilead Sciences has hired a new head of legal and compliance for Australia and New Zealand.
Ric Morgan, who boasts “more than 17 years of experience as a lawyer and leader in pharmaceutical, market access, regulatory, litigation and IP”, is set to become the new head of legal and compliance for Gilead Sciences in Australia and New Zealand.
He joins from Linklaters, where he was a special counsel and deputy leader of the global firm’s healthcare sector practice group. He will be based in Melbourne, where he will lead the company’s in-house legal and business conduct team.
Speaking about his new role, Mr Morgan said: “The healthcare sector has always been where my passion lies and it’s exciting to be joining Gilead Sciences during this unprecedented time.”
“Having already had the pleasure of working closely with the team I’m pleased to join Gilead and support the company’s important work in bringing vital treatments to patients,” he added.
Gilead ANZ general manager Jaime McCoy said the company is “thrilled” to have Mr Morgan join its team.
“Ric has provided excellent external counsel to us over the years and is a pragmatic and strategic business partner. He is a pleasure to work with and I know he will be a huge asset in our work to ensure patients can access Gilead’s diverse range of medicines and treatments,” she said.
Mr Morgan is taking over from Lena Moran-Adams, who has been promoted to the role of head of legal and compliance for Gilead’s international region, and she will be based in the UK.
Commenting on her new role, Ms Moran-Adams said: “The legal team at Gilead [is] very excited to formally bring Mr Morgan’s expertise and insights in-house. I know there is a lot we can all learn from him and from his many years of experience in the field.”